As traditional IPOs continue to face greater scrutiny, companies and advisors are increasingly turning to alternative pathways, including uplistings, direct listings, cross listings, and reverse mergers. Joseph explains why a legitimate uplisting is not a shortcut or a lesser alternative, but rather a strategic path for established public companies that are ready to transition from the OTC markets to a senior exchange. He also discusses the practical realities of today's uplisting process, including trading requirements, reverse split mechanics, FINRA timelines, and the importance of choosing the right exchange and advisor team.

In this episode, Joseph covers:

• Why uplistings are gaining momentum in today's market
• The difference between organic and financing-based uplistings
• How Nasdaq and NYSE evaluate uplisting candidates differently
• Why FINRA timing and reverse split planning are critical to execution
• What separates successful uplisting transactions from those that stall

As the public markets continue to evolve, alternative pathways are becoming an increasingly important part of the capital formation ecosystem. For the right company, an uplisting is no longer simply an alternative to an IPO, it may be the most effective path to reaching a senior exchange. Success, however, depends on careful planning, credible execution, and understanding how today's regulatory and listing environment actually operates.

For more insights from the trenches of the emerging growth markets, follow Joseph Lucosky on LinkedIn or subscribe to him on Substack. And if you found this episode helpful, please share it with someone in the market. And remember, if you have a question and would like us to answer it on a future episode, please send it to us at questions@lucbro.com.

For years, Nasdaq was viewed as the more formulaic and accessible exchange for emerging growth companies, while NYSE was seen as more selective and judgment-driven. But as both exchanges continue tightening standards and increasing scrutiny across the listing process, that gap is rapidly narrowing.

Joseph explains why the old “default Nasdaq” mindset no longer works in today’s market and why exchange selection has become a far more strategic decision tied to fit, probability of success, and how a company is likely to be evaluated throughout the process.

In this episode, Joseph covers:

• Why the old perception of Nasdaq vs. NYSE no longer fully applies
• How Nasdaq’s new discretionary environment changed the listing process
• Why the gap between the exchanges is closing on standards, but not process
• How exchange choice now impacts probability of success and deal strategy
• Why pathway analysis and advisor quality matter more than ever in today’s market

As both exchanges continue raising the bar, exchange selection is no longer simply about prestige, familiarity, or historical assumptions. Companies entering the public markets in 2026 are operating in a far more selective environment where structure, positioning, advisor quality, and execution strategy all play a significant role in determining whether a deal ultimately gets through the process.

For more insights from the trenches of the microcap markets, follow Joseph Lucosky on LinkedIn or subscribe to him on Substack. And if you found this episode helpful, please share it with someone in the market. And remember, if you have a question and would like us to answer it on a future episode, please send it to us at questions@lucbro.com

What may appear to be a straightforward effort to improve market quality has quickly evolved into a much larger debate about capital formation, investor protection, and whether current market structure policies align with Washington’s stated goal of helping more companies access and remain in the public markets. Drawing from recent meetings on Capitol Hill, Joseph discusses why this issue has become more than just a Nasdaq rule filing and what it could mean for emerging growth companies moving forward.

In this episode, Joseph covers:

• What Nasdaq’s proposed $5 million market cap rule would actually do
• Why critics believe the proposal creates an automatic delisting cliff
• How the rule could impact emerging growth and innovation companies
• The potential effects on capital raising, liquidity, and investor confidence
• Why the proposal is attracting attention from policymakers in Washington

As regulators, exchanges, and lawmakers continue debating the future of the public markets, the outcome of this proposal could have significant implications for smaller public companies and the broader emerging growth ecosystem. For founders, boards, investors, and advisors, understanding the stakes has never been more important.

For more insights from the trenches of the microcap markets, follow Joseph Lucosky on LinkedIn or subscribe to him on Substack. And if you found this episode helpful, please share it with someone in the market. And remember, if you have a question and would like us to answer it on a future episode, please send it to us at questions@lucbro.com

While traditional microcap IPO activity dropped dramatically year over year, the broader market tells a much different story. As exchanges continue tightening standards and increasing discretionary review, founders, bankers, and advisors are increasingly turning toward alternative pathways like uplistings, cross listings, and direct listings.

Joseph explains how the market has moved from a volume-driven environment to a far more selective and strategic one, where structure, positioning, and pathway analysis now matter more than ever.

In this episode, Joseph covers:

• Why Q1 2026 was not simply a “slower” market
• The dramatic decline in traditional microcap IPO volume and what caused it
• How Nasdaq and NYSE rule changes reshaped the landscape
• Why uplistings, cross listings, and direct listings surged in activity
• The growing importance of pathway analysis for founders and advisors
• How foreign private issuers are adapting to the new environment
• Why bigger deals are increasingly favored in today’s market
• What founders, boards, bankers, and consultants should be doing differently right now

Traditional IPO volume may have declined, but activity across alternative pathways accelerated as the market adapted to a more selective and strategic environment. Companies approaching the public markets in 2026 are facing a very different landscape than they were even a year ago, one where structure, positioning, and execution strategy play a far greater role in determining which deals move forward.

For more insights from the trenches of the microcap markets, follow Joseph Lucosky on LinkedIn or subscribe to him on Substack. And if you found this episode helpful, please share it with someone in the market. And remember, if you have a question and would like us to answer it on a future episode, please send it to us at questions@lucbro.com.

On this first episode of Inside the Emerging Growth Markets, Joseph Lucosky breaks down what’s really happening behind the scenes as the microcap markets move from a rules-based system to a discretionary one, and what that means for founders, boards, and deal teams trying to get public today.

From the outside, the market looks active. But beneath the surface, scrutiny is higher, timelines are longer, and the bar to list has fundamentally changed. You can no longer just check boxes, deals are being evaluated holistically, from management teams and capital structure to advisors and investor quality.

Joseph shares a real-time view from the trenches, including:

• Why hitting minimum listing requirements is no longer enough
• How Nasdaq’s new discretionary rule (IM-5101-3) is reshaping the process
• What separates deals that get approved from those that stall
• The biggest mistake founders and advisors are still making
• The three critical moves every company should make right now

This isn’t a shutdown, it’s an upgrade. The market is recalibrating. The bar is being raised across the entire ecosystem. And the companies that recognize that change early, and prepare for it with the right structure, the right team, and the right advisors, are the ones that will get through.

For more insights from the trenches of the microcap markets, follow Joseph Lucosky on LinkedIn or subscribe to him on Substack. And if you found this episode helpful, please share it with someone in the market. And remember, if you have a question and would like us to answer it on a future episode, please send it to us at questions@lucbro.com.

Inside the Emerging Growth Markets is a real-time briefing from the trenches, hosted by Joseph Lucosky, Managing Partner of Lucosky Brookman LLP.

Wall Street–trained and founder-focused, Joe has spent the last two decades advising ambitious entrepreneurs, founders, boards, investors, and investment bankers across some of the most active and dynamic parts of the capital markets.

This show is built for founders preparing to go public, executives navigating life as a listed company, and professionals operating across the emerging growth ecosystem, those who want to understand how this market actually works today.

Each episode breaks down what’s being seen in real time across IPOs and other listings, reverse mergers, SPACs, secondary offerings, and the evolving regulatory landscape, so you can make better decisions and execute at a higher level.

The goal is simple:

To give you a clear view of what’s happening in the emerging growth and microcap markets, and more importantly, what you should be doing about it.

Because in this market, understanding how it really works can make all the difference.